PDCD1 and neoplasm: [404] reported that the combination of CAR‐NK cells and anti‐PD‐1 antibodies promoted cytotoxic T lymphocyte infiltration into the tumor site, triggering in situ immune responses and achieving stronger tumoricidal activity in advanced glioblastoma.